US Microcrystalline Cellulose (MCC) demand remains firm in the pharmaceutical, food, and cosmetic industries with strong downstream consumption backing market fundamentals. Prices eased in August 2025 with moderate fall due to better level of inventory, falling input price, and supportive export climate from Asia. Furthermore, with ongoing weaker freight rates and a weak US dollar, Microcrystalline cellulose expenses will plateau in the short term as cost mitigation offsets demand resilience and cautious procurement planning.
Key Highlights
-
August Price Correction: Microcrystalline cellulose prices dipped due to improved inventories and lower wood pulp and energy costs.
-
Global Supply Recovery: China’s manufacturing rebound and favorable export terms support price stabilization. However, the market purchasing sentiments continue to remain muted.
-
Qx Outlook: Prices likely to remain stable through Qx xxxx, with demand fundamentals offsetting cost relief.
With respect to the demand side is concerned, the downstream purchasing for Microcrystalline cellulose across the pharmaceutical sector remain the biggest usage in the U.S., namely in tablet binding and bulking use in generics and OTCs. However, the imports for various products including the microcrystalline cellulose witnessed a significant downturn during the month of august ahead of the mixed of regulatory, trade and market factors. Initially, strict enforcement of Uyghur forced labor prevention act (UFLPA) lead to a heightened customer inspections and significant rejections...
